Matches in Wikidata for { <http://www.wikidata.org/entity/Q91070042> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91070042 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91070042 description "scientific article published on 31 October 2019" @default.
- Q91070042 description "wetenschappelijk artikel" @default.
- Q91070042 description "наукова стаття, опублікована 31 жовтня 2019" @default.
- Q91070042 name "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 name "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 type Item @default.
- Q91070042 label "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 label "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 prefLabel "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 prefLabel "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 P1433 Q91070042-CC833D78-B71B-413A-BD07-7D9E1FD3B7D3 @default.
- Q91070042 P1476 Q91070042-44BA472F-8982-4503-87F3-0E158355E9A7 @default.
- Q91070042 P2093 Q91070042-1EB1F692-B2F1-463C-83C4-AE8528854AF5 @default.
- Q91070042 P2093 Q91070042-25391229-CD9B-401C-8A37-870BBAE1131D @default.
- Q91070042 P2093 Q91070042-3B3324AA-2ACD-400B-AC7F-21B146A42DA8 @default.
- Q91070042 P2093 Q91070042-79835501-A525-4B81-8408-2BB891A2DF28 @default.
- Q91070042 P2093 Q91070042-98596BEF-4E79-4E78-B3A4-7DAAB59182F2 @default.
- Q91070042 P2093 Q91070042-BEE2A321-DB65-4FB9-A9D5-39C90C94160B @default.
- Q91070042 P2093 Q91070042-D474B849-573F-4B5F-8A03-F624AC008A24 @default.
- Q91070042 P304 Q91070042-19DEC43F-4325-4968-A22D-EAF53370A59B @default.
- Q91070042 P31 Q91070042-2590AF1D-B350-446D-9372-D9512748332D @default.
- Q91070042 P356 Q91070042-33C40EE6-036D-46E2-AC7D-E72E9D2B0DC4 @default.
- Q91070042 P478 Q91070042-5C138792-95F5-4536-B1A9-0C6CA9F1525A @default.
- Q91070042 P50 Q91070042-D0B728D8-AF0A-4B30-AC71-19DD3DA4BC60 @default.
- Q91070042 P577 Q91070042-7C69BE19-9FB1-43EC-8301-0EFB2BAF4D85 @default.
- Q91070042 P698 Q91070042-FD793190-F893-4910-A7C5-CE4AFFC44344 @default.
- Q91070042 P921 Q91070042-886A710A-7453-40A5-80AB-4932BCA022D5 @default.
- Q91070042 P921 Q91070042-990469E4-5162-402D-9993-F833E3E38C85 @default.
- Q91070042 P356 J.LFS.2019.116880 @default.
- Q91070042 P698 31678282 @default.
- Q91070042 P1433 Q5256275 @default.
- Q91070042 P1476 "Rolipram optimizes therapeutic effect of bevacizumab by enhancing proapoptotic, antiproliferative signals in a glioblastoma heterotopic model" @default.
- Q91070042 P2093 "Ali Mohammad Alizadeh" @default.
- Q91070042 P2093 "Fatemeh Ramezani Kapourchali" @default.
- Q91070042 P2093 "Hamid Khodayari" @default.
- Q91070042 P2093 "Saeed Khodayari" @default.
- Q91070042 P2093 "Sara Ramezani" @default.
- Q91070042 P2093 "Shahrokh Yousefzadeh-Chabok" @default.
- Q91070042 P2093 "Zoheir Reihanian" @default.
- Q91070042 P304 "116880" @default.
- Q91070042 P31 Q13442814 @default.
- Q91070042 P356 "10.1016/J.LFS.2019.116880" @default.
- Q91070042 P478 "239" @default.
- Q91070042 P50 Q85035380 @default.
- Q91070042 P577 "2019-10-31T00:00:00Z" @default.
- Q91070042 P698 "31678282" @default.
- Q91070042 P921 Q282142 @default.
- Q91070042 P921 Q413299 @default.